
-
MoonLake Immunotherapies NASDAQ:MLTX
Location: | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
2.266B
Cash
493.9M
Avg Qtr Burn
-20.11M
Short % of Float
29.56%
Insider Ownership
15.23%
Institutional Own.
-
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Sonelokimab Details Hidradenitis suppurativa | Phase 3 Data readout | |
Sonelokimab Details Psoriatic arthritis | Phase 3 Data readout | |
Sonelokimab Details Hidradenitis suppurativa | Phase 3 Data readout | |
Sonelokimab Details Palmoplantar pustulosis | Phase 2 Data readout | |
Sonelokimab Details Axial spondyloarthritis | Phase 2 Data readout |